Allopurinol attenuates left ventricular remodeling and dysfunction after experimental myocardial infarction: A new action for an old drug?

Circulation

Volumn 110, Issue 15, 2004, Pages 2175-2179

  Engberding, Niels ^a   Spiekermann, Stephan ^a   Schaefer, Arnd ^a   Heineke, André ^a   Wiencke, Antje ^a   Müller, Maja ^a   Fuchs, Martin ^a   Hilfiker Kleiner, Denise ^a   Hornig, Burkhard ^a   Drexler, Helmut ^a   Landmesser, Ulf ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

Free radicals; Heart failure; Remodeling

Indexed keywords

ALLOPURINOL; CYTOCHROME C; REACTIVE OXYGEN METABOLITE; SUPEROXIDE DISMUTASE; XANTHINE OXIDASE;

ACUTE HEART INFARCTION; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME INHIBITION; HEART INFARCTION SIZE; HEART LEFT VENTRICLE FAILURE; HEART PROTECTION; HEART VENTRICLE REMODELING; IMMUNOBLOTTING; MALE; MOUSE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ALLOPURINOL; ANIMALS; DRUG EVALUATION, PRECLINICAL; FIBROSIS; LIGATION; MALE; MICE; MICE, INBRED C57BL; MYOCARDIAL INFARCTION; OXIDATIVE STRESS; RANDOM ALLOCATION; REACTIVE OXYGEN SPECIES; SUPEROXIDES; VENTRICULAR DYSFUNCTION, LEFT; VENTRICULAR REMODELING; XANTHINE OXIDASE;

EID: 20844461656     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.0000144303.24894.1C     Document Type: Article

References (18)

1. Pfeffer MA, Braunwald E. Ventricular remodeling after myocardial infarction: experimental observations and clinical implications. Circulation. 1990;81:1161-1172.
2. Kinugawa S, Tsutsui H, Hayashidani S, et al. Treatment with dimethylthiourea prevents left ventricular remodeling and failure after experimental myocardial infarction in mice: role of oxidative stress. Circ Res. 2000;87:392-398.
3. Ekelund UE, Harrison RW, Shokek O, et al. Intravenous allopurinol decreases myocardial oxygen consumption and increases mechanical efficiency in dogs with pacing-induced heart failure. Circ Res. 1999:85:437-445.
4. Cappola TP, Kass DA, Nelson GS, et al. Allopurinol improves myocardial efficiency in patients with idiopathic dilated cardiomyopathy. Circulation. 2001;104:2407-2411.
5. Landmesser U, Spiekermann S, Dikalov S, et al. Vascular oxidative stress and endothelial dysfunction in patients with chronic heart failure: role of xanthine oxidase and extracellular Superoxide dismutase. Circulation. 2002;106:3073-3078.
6. Siwik DA, Tzortzis JD, Pimental DR. et al. Inhibition of copper-zinc superoxide dismutase induces cell growth, hypertrophic phenotype, and apoptosis in neonatal rat cardiac myocytes in vitro. Circ Res. 1999:85:147-153.
7. Gao WD, Liu Y, Marban E. Selective effects of oxygen free radicals on excitation-contraction coupling in ventricular muscle: implications for the mechanism of stunned myocardium. Circulation. 1996;94:2597-2604.
8. Fuchs M, Hilfiker A, Kaminski K, et al. Role of interleukin-6 for left ventricular remodeling and survival after experimental myocardial infarction. FASEB J. 2003;17:2118-2120.
9. Wu X, Wakamiya M, Vaishnav S, et al. Hyperuricemia and urate nephropathy in urate oxidase-deficient mice. Proc Natl Acad Sci USA. 1994;91:742-746.
10. Landmesser U, Dikalov S, Price SR, et al. Oxidation of tetrahydrobiopterin leads to uncoupling of endothelial cell nitric oxide synthase in hypertension. J Clin Invest. 2003:111:1201-1209.
11. phox in vascular oxidative stress and hypertension caused by angiotensin II. Hypertension. 2002;40:511-515.
12. Schaefer A, Klein G, Brand B, et al. Evaluation of left ventricular diastolic function by pulsed Doppler tissue imaging in mice. J Am Soc Echocardiogr. 2003;16:1144-1149.
13. Wollen KC, Studer R, Doerfer K, et al. Differential effects of kinins on cardiomyocyte hypertrophy and interstitial collagen matrix in the surviving myocardium after myocardial infarction in the rat. Circulation. 1997;95:1910-1917.
14. 2+-sensitizing property of xanthine oxidase inhibitors. Circ Res. 1998;83:423-430.
15. Farquharson CA, Butler R, Hill A, et al. Allopurinol improves endothelial dysfunction in chronic heart failure. Circulation. 2002;106:221-226.
16. Anker SD, Doehner W, Rauchhaus M, et al. Uric acid and survival in chronic heart failure: validation and application in metabolic, functional, and hemodynamic staging. Circulation. 2003:107:1991-1997.
17. Hare JM, Johnson RJ. Uric acid predicts clinical outcomes in heart failure: insights regarding the role of xanthine oxidase and uric acid in disease pathophysiology. Circulation. 2003;107:1951-1953.
18. Doehner W, Schoene N, Rauchhaus M, et al. Effects of xanthine oxidase inhibition with allopurinol on endothelial function and peripheral blood flow in hyperuricemic patients with chronic heart failure: results from 2 placebo-controlled studies. Circulation. 2002;105:2619-2624.